✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. ResearchHempCBGPainRheumatoid ArthritisSafetyPharmaceuticals Clinical Summary # Clinical Summary Cannabigerol (CBG), a non-intoxicating cannabinoid, demonstrated anti-inflammatory and...
Pilot Cross-Sectional Study Assessing the Correlation between Marijuana Use and Rheumatoid Arthritis and Systemic Lupus Erythematosus Exacerbations.
Cannabis use is increasing among patients with autoimmune rheumatic diseases, often for symptom relief; however, its impact on disease activity remains uncle…
Cannabidiol synergizes with methotrexate to attenuate rheumatoid arthritis via STAT3/NF-ฮบB signalling-mediated M1 macrophage polarization.
A preclinical study investigated CBD methotrexate combination therapy for rheumatoid arthritis in mice. While molecular mechanisms appear promising, significant clinical research gaps remain before human applications can be considered.
Cannabidiol synergizes with methotrexate to attenuate rheumatoid arthritis via STAT3/NF-ฮบB signalling-mediated M1 macrophage polarization.
Methotrexate (MTX) is the anchor drug for rheumatoid arthritis (RA) treatment, but its clinical application is limited by dose-dependent adverse events, such…
Pilot Cross-Sectional Study Assessing the Correlation between Marijuana Use and Rheumatoid Arthritis and Systemic Lupus Erythematosus Exacerbations.
Cannabis use is increasing among patients with autoimmune rheumatic diseases, often for symptom relief; however, its impact on disease activity remains uncle…